Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03525028Unknown
Randomised, double-blind trial in autoimmune uveitis comparing Metformin group with Placebo group (2 arms). Primary endpoint: The incidence of abnormal metabolic indexes at 24 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03525028.